DWM
TXG icon

Dynasty Wealth Management’s 10x Genomics TXG Stock Holding History

Dynasty Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$693K Sell
18,067
-1,852
-9% -$48.5K 0.01% 223
2026
Q1 		$423K Sell
19,919
-5,336
-21% -$107K ﹤0.01% 252
2025
Q4 		$412K Buy
25,255
+1,307
+5% +$19.7K ﹤0.01% 252
2025
Q3 		$280K Buy
+23,948
New +$312K ﹤0.01% 268

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dynasty Wealth Management's TXG Position: Q2 2026 in Review

Dynasty Wealth Management reduced its 10x Genomics (TXG) stake by 9.3% in Q2 2026, selling an estimated $48.5K and leaving 18,067 shares worth $693K. The position accounts for 0.01% of the portfolio, ranked #223.

Dynasty Wealth Management first reported a position in TXG in Q3 2025 and has held it in 4 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Dynasty Wealth Management held 18,067 shares of 10x Genomics worth $693K as of Q2 2026.
  • Dynasty Wealth Management sold 1,852 10x Genomics shares in Q2 2026, an estimated $48.5K.
  • 10x Genomics made up 0.01% of Dynasty Wealth Management's portfolio in Q2 2026, its #223 holding.
  • Dynasty Wealth Management first reported a position in 10x Genomics in Q3 2025 and has held it in 4 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Dynasty Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.